[1]
M. K. Abdulfattah and M. A. Al-naqqash, “The Clinico-epidemiologic Characteristics of Iraqi Patients with Neuroendocrine Tumors and Their Response to Long Acting Octreotide”, JFacMedBagdad, vol. 58, no. 4, pp. 312–315, Jan. 2016, doi: 10.32007/jfacmedbagdad.584271.